March 2, 2010 — Leg arteries that become narrow decrease blood circulation and can cause these extremities to ache or cramp when a person begins exercise. This condition is referred to as intermittent claudication (IC). Although the pain may subside with rest, IC should be taken seriously because it can increase the risk of heart attack and stroke.

March 8, 2010 – A self-expanding and disconnectable stent today gained CE mark approval in Europe to treat acute coronary syndrome (ACS).

March 8, 2010 – Advanced visualization and decision support solutions maker TeraRecon was awarded Frost and Sullivan’s “Company of the Year Award,” in the category of medical imaging, advanced visualization applications, Europe 2010. This award represents the fifth time TeraRecon has been recognized with an award from the healthcare market-consulting firm.

March 8, 2010 – Six-month follow-up data on the Stentys drug-eluting and bare metal stents showed a 4 percent restenosis rate in complex lesions.

March 8, 2010 – Bifurcation stent developer Tryton Medical Inc. recently announced its Tryton stent implants reached a milestone of 750 patients and recently had its first implants in Portugal and Austria.

March 5, 2010 – Experts will lead an evening symposium during ACC 2010 that will cover the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease. Those attending will be exposed to the latest clinical trial data on current and second-generation drug-eluting stent therapies.

March 5, 2010 - Vendor neutral archives virtualize enterprise storage and provide on-demand delivery of images and data to locations throughout the enterprise, regardless of where the information is physically stored or where it originated. These capabilities are engineered to streamline IT tasks and help healthcare providers reduce expenses.

March 5, 2010 - After wavering between an initial offer from Thoma Bravo, LLC for $5.35 per share, and an offer from Merge Healthcare Inc.

March 4, 2010 – During ACC 2010, cardiovascular IT solutions from Siemens will be shown to help optimize clinical workflows through integration of imaging and information, and are designed to make healthcare faster, better and more cost-effective.

March 3, 2010 – Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to new market research from Datamonitor.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now